Literature DB >> 8976872

Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis.

J E Smithson1, B F Warren, S Young, R Pigott, D P Jewell.   

Abstract

Using a technique of tolerization, a murine monoclonal antibody (MAb 2E8) has been raised which displays regional differences in reactivity in the epithelium of the normal human colon and increased reactivity in active ulcerative colitis. MAb 2E8 (IgG1) was highly colon-specific and gave higher immunoperoxidase staining scores in the proximal colonic mucosa compared with paired rectal sections (P < 0.02). Expression of the antigen reactive with MAb 2E8 was enhanced in active ulcerative colitis compared with quiescent ulcerative colitis (P < 0.05) and normal controls (P < 0.001). Western blotting and indirect immunofluorescent screening on transfected cell lines established that MAb 2E8 was reactive with carcinoembryonic antigen (CEA). This is the first demonstration of regional differences in the expression of CEA in the normal colon and indicates upregulation of this molecule in active ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976872     DOI: 10.1002/(SICI)1096-9896(199610)180:2<146::AID-PATH643>3.0.CO;2-E

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.

Authors:  Dan Blat; Ehud Zigmond; Zoya Alteber; Tova Waks; Zelig Eshhar
Journal:  Mol Ther       Date:  2014-03-06       Impact factor: 11.454

2.  Altered expression of mucins throughout the colon in ulcerative colitis.

Authors:  J E Smithson; A Campbell; J M Andrews; J D Milton; R Pigott; D P Jewell
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

3.  The other face of chimeric antigen receptors.

Authors:  Gianpietro Dotti
Journal:  Mol Ther       Date:  2014-05       Impact factor: 11.454

4.  Elevation of carcinoembryonic antigen coinciding with disease activity of ulcerative colitis.

Authors:  Sayaka Yamaguchi; Yoshiaki Takeuchi; Katsuhito Arai; Chitose Oishi; Tomoko Norose; Toshiko Yamochi-Onizuka; Miki Kushima; Hidekazu Ota; Michio Imawari
Journal:  Clin J Gastroenterol       Date:  2012-02-12

Review 5.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

Review 6.  From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment.

Authors:  Stephan Klöß; Susann Dehmel; Armin Braun; Michael J Parnham; Ulrike Köhl; Susanne Schiffmann
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

Review 7.  Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.

Authors:  Qunfang Zhang; Weihui Lu; Chun-Ling Liang; Yuchao Chen; Huazhen Liu; Feifei Qiu; Zhenhua Dai
Journal:  Front Immunol       Date:  2018-10-12       Impact factor: 7.561

8.  A case of stricture-type ischemic colitis from excessive alcohol consumption, with follow-up to rule out colon cancer.

Authors:  Yu Watahiki; Keietsu Saito; Yuto Ishizaki; Kuniyoshi Yamanobe; Keiichi Sagawa; Kazumichi Abe; Hiromasa Ohira
Journal:  Fukushima J Med Sci       Date:  2020-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.